(Q51961545)

19 April 2018

title

Health-related quality of life in individuals infected with HIV in the era of HAART. (English)

1 reference

19 April 2018

1 reference

2

1 reference

19 April 2018

Amanda Mocroft

3

object named as

Mocroft A

1 reference

19 April 2018

author name string

Miners AH

1

1 reference

19 April 2018

Youle M

4

1 reference

19 April 2018

Fisher M

5

1 reference

19 April 2018

Johnson M

6

1 reference

19 April 2018

publication date

1 November 2001

1 reference

19 April 2018

published in

HIV Clinical Trials

1 reference

19 April 2018

volume

2

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

484-492

1 reference

19 April 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Quality of life assessment comes of age in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQOL-HIV Validation Group. Medical Outcomes Study HIV Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Measuring health-related quality of life among patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Variations in population health status: results from a United Kingdom national questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F48ET-TT7G-35RA-D4C3

10.1310/48ET-TT7G-35RA-D4C3

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018